- Home
- ACNB vs SANA Comparison
ACNB vs SANA Comparison
Compare ACNB & SANA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACNB
- SANA
- Stock Information
- Founded
- ACNB 1857
- SANA 2018
- Country
- ACNB United States
- SANA United States
- Employees
- ACNB N/A
- SANA N/A
- Industry
- ACNB Major Banks
- SANA Medicinal Chemicals and Botanical Products
- Sector
- ACNB Finance
- SANA Health Care
- Exchange
- ACNB Nasdaq
- SANA Nasdaq
- Market Cap
- ACNB 449.9M
- SANA 519.8M
- IPO Year
- ACNB N/A
- SANA 2021
- Fundamental
- Price
- ACNB $41.57
- SANA $2.17
- Analyst Decision
- ACNB Strong Buy
- SANA Strong Buy
- Analyst Count
- ACNB 4
- SANA 5
- Target Price
- ACNB $50.00
- SANA $9.50
- AVG Volume (30 Days)
- ACNB 19.6K
- SANA 3.9M
- Earning Date
- ACNB 07-23-2025
- SANA 05-08-2025
- Dividend Yield
- ACNB 3.25%
- SANA N/A
- EPS Growth
- ACNB N/A
- SANA N/A
- EPS
- ACNB 2.79
- SANA N/A
- Revenue
- ACNB $113,448,000.00
- SANA N/A
- Revenue This Year
- ACNB $38.67
- SANA N/A
- Revenue Next Year
- ACNB $5.26
- SANA N/A
- P/E Ratio
- ACNB $14.90
- SANA N/A
- Revenue Growth
- ACNB 8.66
- SANA N/A
- 52 Week Low
- ACNB $30.24
- SANA $1.26
- 52 Week High
- ACNB $50.72
- SANA $8.17
- Technical
- Relative Strength Index (RSI)
- ACNB 43.86
- SANA 59.16
- Support Level
- ACNB $41.23
- SANA $1.81
- Resistance Level
- ACNB $42.74
- SANA $2.35
- Average True Range (ATR)
- ACNB 0.79
- SANA 0.21
- MACD
- ACNB -0.30
- SANA 0.05
- Stochastic Oscillator
- ACNB 10.76
- SANA 76.00
About ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.